Cargando…
Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
Accurate and precise point-of-care (POC) testing for C-reactive protein (CRP) can help support healthcare providers in the clinical management of patients. Here, we compared the analytical performance of 17 commercially available POC CRP tests to enable more decentralized use of the tool. The follow...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858008/ https://www.ncbi.nlm.nih.gov/pubmed/36662693 http://dx.doi.org/10.1371/journal.pone.0267516 |
_version_ | 1784873991590117376 |
---|---|
author | Calarco, Serafina Fernandez-Carballo, B. Leticia Keller, Thomas Weber, Stephan Jakobi, Meike Marsall, Patrick Schneiderhan-Marra, Nicole Dittrich, Sabine |
author_facet | Calarco, Serafina Fernandez-Carballo, B. Leticia Keller, Thomas Weber, Stephan Jakobi, Meike Marsall, Patrick Schneiderhan-Marra, Nicole Dittrich, Sabine |
author_sort | Calarco, Serafina |
collection | PubMed |
description | Accurate and precise point-of-care (POC) testing for C-reactive protein (CRP) can help support healthcare providers in the clinical management of patients. Here, we compared the analytical performance of 17 commercially available POC CRP tests to enable more decentralized use of the tool. The following CRP tests were evaluated. Eight quantitative tests: QuikRead go (Aidian), INCLIX (Sugentech), Spinit (Biosurfit), LS4000 (Lansionbio), GS 1200 (Gensure Biotech), Standard F200 (SD Biosensor), Epithod 616 (DxGen), IFP-3000 (Xincheng Biological); and nine semi-quantitative tests: Actim CRP (ACTIM), NADAL Dipstick (nal von minden), NADAL cassette (nal von minden), ALLTEST Dipstick (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10-40-80 (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10–30 (Hangzhou Alltest Biotech), Biotest (Hangzhou Biotest Biotech), BTNX Quad Line (BTNX), BTNX Tri Line (BTNX). Stored samples (n = 660) had previously been tested for CRP using Cobas 8000 Modular analyzer (Roche Diagnostics International AG, Rotkreuz, Switzerland (reference standards). CRP values represented the clinically relevant range (10–100 mg/L) and were grouped into four categories (<10 mg/L, 10–40 mg/L or 10–30 mg/L, 40–80 mg/L or 30–80 mg/L, and > 80mg/L) for majority of the semi-quantitative tests. Among the eight quantitative POC tests evaluated, QuikRead go and Spinit exhibited better agreement with the reference method, showing slopes of 0.963 and 0.921, respectively. Semi-quantitative tests with the four categories showed a poor percentage agreement for the intermediate categories and higher percentage agreement for the lower and upper limit categories. Analytical performance varied considerably for the semi-quantitative tests, especially among the different categories of CRP values. Our findings suggest that quantitative tests might represent the best choice for a variety of use cases, as they can be used across a broad range of CRP categories. |
format | Online Article Text |
id | pubmed-9858008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-98580082023-01-21 Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system Calarco, Serafina Fernandez-Carballo, B. Leticia Keller, Thomas Weber, Stephan Jakobi, Meike Marsall, Patrick Schneiderhan-Marra, Nicole Dittrich, Sabine PLoS One Research Article Accurate and precise point-of-care (POC) testing for C-reactive protein (CRP) can help support healthcare providers in the clinical management of patients. Here, we compared the analytical performance of 17 commercially available POC CRP tests to enable more decentralized use of the tool. The following CRP tests were evaluated. Eight quantitative tests: QuikRead go (Aidian), INCLIX (Sugentech), Spinit (Biosurfit), LS4000 (Lansionbio), GS 1200 (Gensure Biotech), Standard F200 (SD Biosensor), Epithod 616 (DxGen), IFP-3000 (Xincheng Biological); and nine semi-quantitative tests: Actim CRP (ACTIM), NADAL Dipstick (nal von minden), NADAL cassette (nal von minden), ALLTEST Dipstick (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10-40-80 (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10–30 (Hangzhou Alltest Biotech), Biotest (Hangzhou Biotest Biotech), BTNX Quad Line (BTNX), BTNX Tri Line (BTNX). Stored samples (n = 660) had previously been tested for CRP using Cobas 8000 Modular analyzer (Roche Diagnostics International AG, Rotkreuz, Switzerland (reference standards). CRP values represented the clinically relevant range (10–100 mg/L) and were grouped into four categories (<10 mg/L, 10–40 mg/L or 10–30 mg/L, 40–80 mg/L or 30–80 mg/L, and > 80mg/L) for majority of the semi-quantitative tests. Among the eight quantitative POC tests evaluated, QuikRead go and Spinit exhibited better agreement with the reference method, showing slopes of 0.963 and 0.921, respectively. Semi-quantitative tests with the four categories showed a poor percentage agreement for the intermediate categories and higher percentage agreement for the lower and upper limit categories. Analytical performance varied considerably for the semi-quantitative tests, especially among the different categories of CRP values. Our findings suggest that quantitative tests might represent the best choice for a variety of use cases, as they can be used across a broad range of CRP categories. Public Library of Science 2023-01-20 /pmc/articles/PMC9858008/ /pubmed/36662693 http://dx.doi.org/10.1371/journal.pone.0267516 Text en © 2023 Calarco et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Calarco, Serafina Fernandez-Carballo, B. Leticia Keller, Thomas Weber, Stephan Jakobi, Meike Marsall, Patrick Schneiderhan-Marra, Nicole Dittrich, Sabine Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system |
title | Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system |
title_full | Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system |
title_fullStr | Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system |
title_full_unstemmed | Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system |
title_short | Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system |
title_sort | analytical performance of 17 commercially available point-of-care tests for crp to support patient management at lower levels of the health system |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858008/ https://www.ncbi.nlm.nih.gov/pubmed/36662693 http://dx.doi.org/10.1371/journal.pone.0267516 |
work_keys_str_mv | AT calarcoserafina analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem AT fernandezcarballobleticia analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem AT kellerthomas analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem AT weberstephan analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem AT jakobimeike analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem AT marsallpatrick analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem AT schneiderhanmarranicole analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem AT dittrichsabine analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem |